The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Natural History of Very Severe Aortic Stenosis
Open accessAbstract
Background— We sought to assess the outcome of asymptomatic patients with very severe aortic stenosis. Methods and Results— We prospectively followed 116 consecutive asymptomatic patients (57 women; age, 67±16 years) with very severe isolated aortic stenosis defined by a peak aortic jet velocity (AV-Vel) ≥5.0 m/s (average AV-Vel, 5.37±0.35 m/s; valve area, 0.63±0.12 cm 2 ). During a median follow-up of 41 months (interquartile range, 26 to 63 months), 96 events occurred (indication for aortic valve replacement, 90; cardiac deaths, 6). Event-free survival was 64%, 36%, 25%, 12%, and 3% at 1, 2, 3, 4, and 6 years, respectively. AV-Vel but not aortic valve area was shown to independently affect event-free survival. Patients with an AV-Vel ≥5.5 m/s had an event-free survival of 44%, 25%, 11%, and 4% at 1, 2, 3, and 4 years, respectively, compared with 76%, 43%, 33%, and 17% for patients with an AV-Vel between 5.0 and 5.5 m/s ( P <0.0001). Six cardiac deaths occurred in previously asymptomatic patients (sudden death, 1; congestive heart failure, 4; myocardial infarction, 1). Patients with an initial AV-Vel ≥5.5 m/s had a higher likelihood (52%) of severe symptom onset (New York Heart Association or Canadian Cardiovascular Society class >II) than those with an AV-Vel between 5.0 and 5.5 m/s (27%; P =0.03). Conclusions— Despite being asymptomatic, patients with very severe aortic stenosis have a poor prognosis with a high event rate and a risk of rapid functional deterioration. Early elective valve replacement surgery should therefore be considered in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Authors/Task Force Members, Vahanian, A., Baumgartner, H., Bax, J., Butchart, E., Dion, R., Filippatos, G., Flachskampf, F., Hall, R., Iung, B., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl428 · Cited by 3,593
Self-citationA note on quantifying follow-up in studies of failure time
Schemper, M., & Smith, T. L. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(96)00075-x · Cited by 2,575
Self-citationACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.021 · Cited by 1,702
Predictors of Outcome in Severe, Asymptomatic Aortic Stenosis
Rosenhek, R., Binder, T., Porenta, G., Lang, I., Christ, G., Schemper, M., Maurer, G., & Baumgartner, H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008313430903 · Cited by 1,338
Self-citationOtto, C. M., Burwash, I. G., Legget, M. E., Munt, B. I., Fujioka, M., Healy, N. L., Kraft, C. D., Miyake-Hull, C. Y., & Schwaegler, R. G. (1997) · Circulation · doi:10.1161/01.cir.95.9.2262 · Cited by 1,146
Hammermeister, K., Sethi, G. K., Henderson, W. G., Grover, F. L., Oprian, C., & Rahimtoola, S. H. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00834-2 · Cited by 1,144
Hachicha, Z., Dumesnil, J. G., Bogaty, P., & Pibarot, P. (2007) · Circulation · doi:10.1161/circulationaha.106.668681 · Cited by 959
Pellikka, P. A., Sarano, M. E., Nishimura, R. A., Malouf, J. F., Bailey, K. R., Scott, C. G., Barnes, M. E., & Tajik, A. J. (2005) · Circulation · doi:10.1161/circulationaha.104.495903 · Cited by 864
ROSS, J., & BRAUNWALD, E. (1968) · Circulation · doi:10.1161/01.cir.38.1s5.v-61 · Cited by 725
Biomarkers in Acute Cardiac Disease
Jaffe, A. S., Babuin, L., & Apple, F. S. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.056 · Cited by 639
Cited by
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
Self-citation2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
Guidelines on the management of valvular heart disease (version 2012)
Authors/Task Force Members, Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Barón-Esquivias, G., Baumgartner, H., Borger, M. A., Carrel, T. P., De Bonis, M., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs109 · Cited by 3,559
Self-citation2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000029 · Cited by 2,566
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000932 · Cited by 2,449
Guidelines on the management of valvular heart disease (version 2012)
Authors/Task Force Members, Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Barón-Esquivias, G., Baumgartner, H., Borger, M. A., Carrel, T. P., De Bonis, M., et al. (2012) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezs455 · Cited by 2,009
Self-citation2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 1,982
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O'Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.537 · Cited by 1,642
“Low-dose dobutamine stress testing using echocardiographic or invasive hemodynamic measurements is reasonable in patients with stage D2 AS with all of the following (46-48), (Level of Evidence: B): a.”
Baumgartner, H., Hung, J., Bermejo, J., Chambers, J. B., Edvardsen, T., Goldstein, S., Lancellotti, P., LeFevre, M., Miller, F., & Otto, C. M. (2017) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.02.009 · Cited by 1,349
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.035 · Cited by 1,075
2014 AHA/ACC guideline for the management of patients with valvular heart disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.05.014 · Cited by 989
Baumgartner, H., Hung, J., Bermejo, J., Chambers, J. B., Edvardsen, T., Goldstein, S., Lancellotti, P., LeFevre, M., Miller, F., & Otto, C. M. (2017) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jew335 · Cited by 760
2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Muñoz, D. R., et al. (2018) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2017.12.013 · Cited by 672
Self-citationThe evolving epidemiology of valvular aortic stenosis. The Tromsø Study
Eveborn, G. W., Schirmer, H., Heggelund, G., Lunde, P., & Rasmussen, K. (2013) · Heart · doi:10.1136/heartjnl-2012-302265 · Cited by 648
Aortic-Valve Stenosis — From Patients at Risk to Severe Valve Obstruction
Otto, C. M., & Prendergast, B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1313875 · Cited by 631
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Falk, V., Baumgartner, H., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Muñoz, D. R., et al. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx324 · Cited by 630
Self-citation2021 ESC/EACTS Guidelines for the management of valvular heart disease
Beyersdorf, F., Vahanian, A., Milojevic, M., Praz, F., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2021) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezab389 · Cited by 622
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2022.05.006 · Cited by 527
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · EuroIntervention · doi:10.4244/eij-e-21-00009 · Cited by 372
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
Izumi, C., Eishi, K., Ashihara, K., Arita, T., Otsuji, Y., Kunihara, T., Komiya, T., Shibata, T., Seo, Y., Daimon, M., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0135 · Cited by 367
Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction
Jander, N., Minners, J., Holme, I., Gerdts, E., Boman, K., Brudi, P., Chambers, J. B., Egstrup, K., Kesäniemi, Y. A., Malbecq, W., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.983510 · Cited by 338
Lancellotti, P., Donal, E., Magne, J., Moonen, M., O'Connor, K., Daubert, J.-C., & Pierard, L. A. (2010) · Heart · doi:10.1136/hrt.2009.190942 · Cited by 321
Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis
Généreux, P., Schwartz, A., Oldemeyer, J. B., Pibarot, P., Cohen, D. J., Blanke, P., Lindman, B. R., Babaliaros, V., Fearon, W. F., Daniels, D. V., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2405880 · Cited by 319
Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis
Taniguchi, T., Morimoto, T., Shiomi, H., Ando, K., Kanamori, N., Murata, K., Kitai, T., Kawase, Y., Izumi, C., Miyake, M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.001 · Cited by 317
Early Surgery Versus Conventional Treatment in Asymptomatic Very Severe Aortic Stenosis
Kang, D.-H., Park, S.-J., Rim, J. H., Yun, S.-C., Kim, D.-H., Song, J.-M., Choo, S. J., Park, S. W., Song, J.-K., Lee, J.-W., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909903 · Cited by 298
Généreux, P., Stone, G. W., O’Gara, P. T., Marquis-Gravel, G., Redfors, B., Giustino, G., Pibarot, P., Bax, J. J., Bonow, R. O., & Leon, M. B. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.057 · Cited by 297
Outcomes of Patients With Asymptomatic Aortic Stenosis Followed Up in Heart Valve Clinics
Lancellotti, P., Magne, J., Dulgheru, R., Clavel, M.-A., Donal, E., Vannan, M. A., Chambers, J., Rosenhek, R., Habib, G., Lloyd, G., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.3152 · Cited by 276
Self-citationImaging and Impact of Myocardial Fibrosis in Aortic Stenosis
Bing, R., Cavalcante, J. L., Everett, R. J., Clavel, M.-A., Newby, D. E., & Dweck, M. R. (2019) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2018.11.026 · Cited by 273
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.002 · Cited by 279
Danielsen, R., Aspelund, T., Harris, T. B., & Gudnason, V. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.053 · Cited by 168
“Many, however, will be too ill and frail for either procedure and will need demanding treatment for heart failure, atrial fibrillation and coronary artery disease [8–10].”
BackgroundCurrent Management of Calcific Aortic Stenosis
Lindman, B. R., Bonow, R. O., & Otto, C. M. (2013) · Circulation Research · doi:10.1161/circresaha.111.300084 · Cited by 175
Degenerative calcific aortic stenosis: a natural history
Iung, B., & Vahanian, A. (2012) · Heart · doi:10.1136/heartjnl-2012-302395 · Cited by 105
Assessment of left ventricular function in aortic stenosis
Ozkan, A., Kapadia, S., Tuzcu, M., & Marwick, T. H. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.80 · Cited by 57
“It remains to be determined whether impaired LV mechanics are an indication for earlier valve replacement than is currently supported by guideline recommendations, to prevent overt LV dysfunction in asymptomatic patients”
BackgroundTiming of intervention in asymptomatic patients with valvular heart disease
Baumgartner, H., Iung, B., & Otto, C. M. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa485 · Cited by 57
Metadata
- Authors
- Rosenhek, R., Zilberszac, R., Schemper, M., Czerny, M., Mundigler, G., Graf, S., Bergler-Klein, J., Grimm, M., Gabriel, H., & Maurer, G.
- Venue
- Circulation
- Published
- 2010-01-05
- Volume
- 121
- Issue
- 1
- Pages
- 151-156
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2144119781
- Cited by
- 522
- References
- 28
- FWCI
- 16.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.